Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYAN

Cyanotech (CYAN) Stock Price, News & Analysis

Cyanotech logo

About Cyanotech Stock (NASDAQ:CYAN)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.42
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
N/A
Average Volume
3,483 shs
Market Capitalization
$3.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Stock News Headlines

Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Q3 2025 Cyanotech Corp Earnings Call
See More Headlines

CYAN Stock Analysis - Frequently Asked Questions

Cyanotech Co. (NASDAQ:CYAN) announced its quarterly earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.16) EPS for the quarter. The biotechnology company had revenue of $5.85 million for the quarter. Cyanotech had a negative trailing twelve-month return on equity of 44.71% and a negative net margin of 19.50%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL).

Company Calendar

Last Earnings
11/12/2024
Today
7/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAN
CIK
768408
Employees
95
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.27 million
Net Margins
-19.50%
Pretax Margin
-19.48%
Return on Equity
-44.71%
Return on Assets
-19.12%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
1.06
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$23.07 million
Price / Sales
0.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
0.32

Miscellaneous

Outstanding Shares
7,160,000
Free Float
5,074,000
Market Cap
$3.00 million
Optionable
Not Optionable
Beta
-0.11
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CYAN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners